Dr. Stephane Ledot Joins Inspira Technologies’ Scientific Advisory Board

Expert in Critical Care and Anesthesia

Dr. Stephane Ledot, a world-renowned expert in critical care and anesthesia, has joined Inspira Technologies’ Scientific Advisory Board.

Dr. Ledot is an expert in various clinical fields including Critical Care Medicine, Anesthesia, Extracorporeal Support, and Echocardiography. During his career, he has undertaken a large number of educational duties, including advanced cardiovascular life support (ACLS) instruction, critical care module for physiotherapists instruction, critical care module nursing school instruction, among others. Dr. Ledot is a highly appreciated speaker in the critical care space.
Dr. Stephane Ledot, “It is a real honor to be part of this very exciting journey. Inspira Technologies is a very dynamic company specializing in extracorporeal respiratory system innovation, and I believe it can change the paradigm of treatment of the most severe patients suffering from acute respiratory failure. I am convinced we will see new developments and applications of this technology that will translate into a better outcome for many patients.”
Dr. Ledot received his medical academic education at University Pierre et Marie Curie in Paris, France. His specialization in anesthetics and intensive care was obtained at the university de la Mediterranean in Marseille, France.
In August 2013, Dr. Ledot joined an extracorporeal life support fellowship at the National Health Services, in the United Kingdom. During that time, he was involved in the management and retrieval of patients with severe acute respiratory failure needing extracorporeal support. He stayed an additional year at Harefield Hospital to complete a fellowship in cardiothoracic anesthesia and gained some experience in the management of complex cardiac surgeries, ventricular assist devices, and heart and lung transplant.
Dr. Ledot has completed his accreditation for transesophageal echocardiography (TOE) from the European Association of Cardiovascular Imaging and holds a European Diploma in Intensive Care.
In the last few years, Dr. Ledot has served as a senior clinician in critical care and anesthetics at Royal Brompton & Harefield hospitals and became the director of the extracorporeal membrane oxygenation (ECMO) service and critical care. The Royal Brompton ECMO service is one of the largest in Europe and has been recognized as a center of excellence.
Dagi Ben-Noon, Inspira Technologies’ Chief Executive Officer, commented, “We welcome Dr. Ledot to Inspira Technologies’ Scientific Advisory Board. Dr. Ledot has valuable experience in intensive care medicine. We believe that Dr. Ledot can significantly contribute to our future efforts to introduce our innovative early extracorporeal respiratory support system, the ART device, to the international medical community.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.